“It's Not Like Judgment Day”: Public Understanding of and Reactions to Personalized Genomic Risk Information
Open Access
- 17 December 2011
- journal article
- research article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 21 (3), 423-432
- https://doi.org/10.1007/s10897-011-9476-4
Abstract
The value of genomic risk assessment depends upon patients making appropriate behavioral changes in response to increased risk leading to disease prevention and early detection. To date, few studies have investigated consumers’ response to personalized genomic disease risk information. To address this gap, we conducted semi-structured interviews with 60 adults participating in the Coriell Personalized Medicine Collaborative. The interviews took place after receiving results providing genomic and other risk information for up to eight common complex diseases. We found that participants were most likely to recall results which conferred an increased risk or those of particular personal interest. Participants understood the multi-factorial nature of common complex disease, and generally did not have negative emotional responses or overly deterministic perceptions of their results. Although most participants expressed a desire to use results to improve their health, a minority had actually taken action (behavior change or shared results with their doctor) at the time of the interview. These results suggest that participants have a reasonable understanding of genomic risk information and that provision of genomic risk information may motivate behavior change in some individuals; however additional work is needed to better understand the lack of change seen in the majority of participants.Funding Information
- National Human Genome Research Institute
- National Institutes of Health (1RC1HG005369‐01, 1‐P50HG004487‐01)
This publication has 49 references indexed in Scilit:
- Users’ motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal storiesJournal of Community Genetics, 2011
- Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease RiskThe New England Journal of Medicine, 2011
- Effects of communicating DNA-based disease risk estimates on risk-reducing behavioursEmergencias, 2010
- Personal genomics and individual identities: motivations and moral imperatives of early usersNew Genetics and Society, 2010
- Potential etiologic and functional implications of genome-wide association loci for human diseases and traitsProceedings of the National Academy of Sciences of the United States of America, 2009
- Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome TestingAmerican Journal of Bioethics, 2009
- Genetic Risk Prediction — Are We There Yet?The New England Journal of Medicine, 2009
- An Unwelcome Side Effect of Direct-to-Consumer Personal Genome TestingJAMA, 2008
- Putting science over supposition in the arena of personalized genomicsNature Genetics, 2008
- A vision for the future of genomics researchNature, 2003